Fermented garlic as a functional food strategy for malnutrition: microbial ecology, bioactive compounds, and clinical perspectives
This narrative review provides no direct clinical evidence that fermented garlic improves nutritional outcomes in malnourished humans; the direction of effect remains insufficient to support clinical recommendation.
| Population | Malnourished populations, especially children in low- and middle-income countries with EED |
|---|---|
| Intervention | Fermented garlic (LAB-lactofermented or black garlic via thermal aging) as a complementary functional food |
| Comparator | Not formally specified; implicitly compared to standard nutritional interventions (RUTF, supplementation) |
| Outcome | Intestinal barrier function (permeability); S-allyl-L-cysteine (SAC) concentration after fermentation; GABA concentration after lactic fermentation; Gut microbiota composition; Intestinal inflammation (inflammatory markers); Micronutrient bioavailability; Clinical nutritional outcomes (weight gain, recovery) |
Summary of findings
| Outcome | Effect | 95% CI | Certainty | Clinical relevance | Notes |
|---|---|---|---|---|---|
| Intestinal barrier function (permeability) | No quantitative effect size reported; preclinical data only | — | Very low | — | |
| S-allyl-L-cysteine (SAC) concentration after fermentation | Qualitative increase reported in SAC after lactic fermentation and thermal aging; in the pooled quantitative estimate or 95% CI provided | — | Low | — | |
| GABA concentration after lactic fermentation | Qualitative increase reported via microbial glutamate decarboxylase activity; in the pooled quantitative estimate or 95% CI provided | — | Low | — | |
| Gut microbiota composition | No quantitative effect size reported; in the controlled human trial data available | — | Very low | — | |
| Intestinal inflammation (inflammatory markers) | No quantitative effect size reported; preclinical data only in malnourished context | — | Very low | — | |
| Micronutrient bioavailability | No quantitative effect size reported; mechanistic hypothesis only | — | Very low | — | |
| Clinical nutritional outcomes (weight gain, recovery) | No data reported; in the human clinical trials in malnourished populations identified | — | Very low | — |
Context
Malnutrition affects 735 million people globally and contributes to approximately 45% of deaths in children under 5, primarily through infectious disease. Environmental Enteric Dysfunction (EED) is a subclinical condition that perpetuates malnutrition by impairing intestinal absorption. Interventions targeting gut barrier repair and microbiota modulation are high-priority in low-resource settings.
What the study showed
The review synthesizes preclinical and observational evidence on fermented garlic without presenting data from controlled clinical trials in malnourished populations. Compounds such as SAC and GABA are identified at higher concentrations after lactic fermentation or thermal aging, based on laboratory studies. No absolute or relative figures for clinical outcomes in malnourished humans are reported. The direction of effect in malnourished humans remains unestablished.
How it was done
Narrative review with systematic search elements (PRISMA-style) across PubMed/MEDLINE, Scopus, Google Scholar, and Web of Science. Coverage from January 2010 to March 2026, with pre-2010 foundational studies included where mechanistically essential. Two independent reviewers with consensus-based resolution of discrepancies. No systematic review protocol registration; not a meta-analysis.
Effect magnitude
No effect size quantified for clinical outcomes in humans. The review reports no 95% CI, RR, OR, or SMD for any clinical outcome in malnourished populations.
Risk of bias
This is a narrative review without formal risk-of-bias assessment (RoB 2, ROBINS-I, or AMSTAR-2 were not applied). The absence of controlled clinical trials in the target population is the critical limitation. Extrapolation from preclinical data and healthy populations to malnourished children with EED is unvalidated. The mechanistic distinction between the two fermentation pathways (microbial vs. thermal) is acknowledged but evidence from both is aggregated without statistical separation.
What this study does NOT prove
This study does not prove that fermented garlic improves nutritional outcomes, reduces mortality, or treats malnutrition in humans. It does not establish causality and cannot be generalized to clinical populations without controlled trial data.
In clinical practice
There is insufficient clinical evidence to recommend fermented garlic as a nutritional intervention in malnourished populations. Clinicians should maintain RUTF and established nutritional rehabilitation protocols. Fermented garlic should be considered only within future controlled clinical trial contexts.
Limitations
This is a narrative review without formal risk-of-bias assessment (RoB 2, ROBINS-I, or AMSTAR-2 were not applied). The absence of controlled clinical trials in the target population is the critical limitation. Extrapolation from preclinical data and healthy populations to malnourished children with EED is unvalidated. The mechanistic distinction between the two fermentation pathways (microbial vs. thermal) is acknowledged but evidence from both is aggregated without statistical separation.
What is still missing
Randomized controlled trials in malnourished children with EED in LMICs, measuring primary outcomes of gut barrier function (serum zonulin, lactulose/mannitol ratio), weight gain, and inflammatory markers. Dose-response and safety studies in vulnerable pediatric populations are required before any recommendation can be made.
Technical appendix
Version history
- 1.0 · 2026-07-02 — Auto-generated under Evidence Standard v1.0